`
`Filed: August 8, 2018
`
`
`____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________
`
`MYLAN PHARMACEUTICALS INC.
`
`Petitioner
`
`v.
`
`POZEN INC. and HORIZON PHARMA USA, INC.
`
`Patent Owners
`____________________________
`
`Case No. IPR2017-01995
`U.S. Patent No. 9,220,698
`____________________________
`
`PETITIONER’S NOTICE OF DEPOSITION OF DAVID R. TAFT, PH.D.
`
`
`
`
`
`Please take notice that, pursuant to 37 C.F.R. § 42.53, Petitioner Mylan
`
`Pharmaceuticals Inc. (“Petitioner”) will take the deposition upon oral examination
`
`of David R. Taft, Ph.D.
`
`The deposition will take place on Friday, August 17, 2018, at the offices of
`
`Perkins Coie LLP, 30 Rockefeller Plaza, 22nd Floor, New York, NY, 10112-0085,
`
`starting at 9:00 AM, or at such other time and place as the parties may further agree.
`
`The cross-examination will be taken before a Notary Public or other officer
`
`authorized by law to administer oaths. The deposition will be recorded by audio,
`
`video, and/or stenographic means, to be arranged by Petitioner.
`
`August 8, 2018
`
`
`
`
`
`Respectfully submitted,
`
`/Brandon M. White/
`Brandon M. White, Esq.
`Reg. No. 52,354
`Perkins Coie LLP
`700 Thirteenth Street, N.W.
`Suite 600
`Washington, DC 20005-3960
`bmwhite@perkinscoie.com
`Tel: 202-654-6206
`Fax: 202-654-9681
`Counsel for Petitioner
`Mylan Pharmaceuticals Inc.
`
`- 1 -
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served a true and
`
`correct copy of the foregoing: PETITIONER’S NOTICE OF DEPOSITION OF
`
`DAVID R. TAFT, PH.D. by email to the electronic service addresses for Patent
`
`Owners:
`
`Thomas A. Blinka
`Jonathan G. Graves
`Susan Krumplitsch
`Lauren Krickl
`Ellen Scordino
`Cooley LLP
`zIPR2017-01995@cooley.com
`
`Margaret J. Sampson
`Stephen M. Hash
`Jeffrey S. Gritton
`Baker Botts LLP
`Pozen-vimovoBB@bakerbotts.com
`
`Dated: August 8, 2018
`
`
`
`
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`Reg. No. 52,354
`Counsel for Petitioner Mylan Pharmaceuticals Inc.
`
`